Clinical Trial Update: The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules [Phase 2]

View source ↗

Summary

Phase 2 trial update reports on safety, antiviral activity, and pharmacokinetics of Morphothiadine Mesilate capsules for chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Morphothiadine Mesilate (Morphothiadine Mesilate)

Snippet

Sponsor: Sunshine Lake Pharma Co., Ltd. | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED